Top

Reactions Weekly

Published in:

01-01-2023 | Diseases of the neuromuscular synapses and muscles | Case report

Edrophonium/pembrolizumab/unspecified steroids

Myopathy, ophthalmoplegia and lack of efficacy: case report

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Wanschitz J, et al. Ophthalmoplegia and HyperCKemia in a patient with recurrent thymoma and PD-1 blocking treatment. Nervenheilkunde 38: 287 (plus poster), No. 5, May 2019. Available from: URL: http://doi.org/10.1055/s-0039-1685032 [abstract]

Title: Edrophonium/pembrolizumab/unspecified steroids
Myopathy, ophthalmoplegia and lack of efficacy: case report
Publication date: 01-01-2023
Publisher: Springer International Publishing
Keywords: Diseases of the neuromuscular synapses and muscles
Thymoma
Thymoma
Ophthalmoparesis
Myopathy
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-30706-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Edrophonium/pembrolizumab/unspecified steroids

Myopathy, ophthalmoplegia and lack of efficacy: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Antithymocyte globulin/ciclosporin/mycophenolate mofetil

Tozinameran

Rituximab

Amiodarone/azathioprine/beta-adrenergic-receptor-antagonists

Multiple drugs

Posaconazole